Investment Thesis
Pfizer (PFE) is a large-cap ($232B) global biopharmaceutical company widely known for the development of the blockbuster cardiovascular drug, Lipitor. Lipitor is perhaps the most recognized statin drug that is used clinically and over the counter to lower bad cholesterol, LDL-C. Pfizer is also a proven pioneer of therapeutics for HIV infection, autoimmune, and gastrointestinal diseases as well as hematological and oncological ailments. Presently, it is clinically assessing the therapeutic effects of small drug molecules targeting the fibrotic liver disease, NASH.
Although a late-starter to clinically developing its NASH pipeline, Pfizer is now